Related Experiment Video
Updated: May 23, 2026
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
A proteomic analysis of MCLR-induced neurotoxicity: implications for Alzheimer's disease
1College of Fisheries, Huazhong Agricultural University, Wuhan 430070, China.
Abstract:
Cyanobacteria-derived microcystin-leucine-arginine (MCLR), commonly characterized as a hepatotoxin, has recently been found to show neurotoxicity, but the exact mechanism is still unknown. To further our understanding of the neurotoxic effects of MCLR and the mechanisms behind it, we used two-dimensional gel electrophoresis and mass spectrometry analysis to identify global protein profiles associated with MCLR-induced neurotoxicity. MCLR-treated hippocampi showed alterations in proteins involved in cytoskeleton, neurodegenerative disease, oxidative stress, apoptosis, and energy metabolism. After validation by Western blot and quantitative real-time PCR, the expressions of three proteins related to neurodegenerative disease, septin 5, α-internexin, and α-synuclein, were identified to be altered by MCLR exposure. Based on our proteomic analysis that MCLR toxicity might be linked to neurodegeneration, we examined the activity of serine/threonine-specific protein phosphatases (PPs), which are markers of neurodegenerative disease. MCLR was found to induce inhibition of PPs and abnormal hyperphosphorylation of the neuronal microtubule-associated protein tau. This was found to lead to impairment of learning and memory, accompanied by severe histological damage and neuronal apoptosis in the hippocampal CA1 regions of rats. Our results support the hypothesis that MCLR could induce neurotoxic effects, the reason for which could be attributed to the disruption of the cytoskeleton, oxidative stress, and inhibition of PPs in the hippocampus. Moreover, MCLR was found to induce tau hyperphosphorylation, spatial memory impairment, neuronal degenerative changes, and apoptosis, suggesting that this cyanotoxin may contribute to Alzheimer's disease in humans.
Insights
Microcystin-leucine-arginine (MCLR), a cyanotoxin, causes neurotoxicity by disrupting the cytoskeleton and inhibiting protein phosphatases in the hippocampus. This leads to tau hyperphosphorylation, memory impairment, and neuronal apoptosis, potentially contributing to Alzheimer's disease.
Area of Science:
- Neuroscience
- Toxicology
- Biochemistry
Background:
- Microcystin-leucine-arginine (MCLR) is a cyanotoxin known for hepatotoxicity.
- Emerging evidence suggests MCLR also exhibits neurotoxic properties, but the underlying mechanisms remain unclear.
Purpose of the Study:
- To elucidate the mechanisms of MCLR-induced neurotoxicity.
- To identify global protein expression changes in the hippocampus following MCLR exposure.
Main Methods:
- Proteomic analysis using two-dimensional gel electrophoresis and mass spectrometry.
- Validation of protein expression changes via Western blot and quantitative real-time PCR.
- Assessment of protein phosphatase activity and tau protein phosphorylation levels.
Main Results:
- MCLR exposure altered hippocampal proteins involved in cytoskeleton, neurodegeneration, oxidative stress, apoptosis, and energy metabolism.
- Expression of septin 5, α-internexin, and α-synuclein were significantly altered.
- MCLR inhibited protein phosphatases, leading to tau hyperphosphorylation, impaired learning and memory, hippocampal damage, and neuronal apoptosis.
Conclusions:
- MCLR induces neurotoxic effects through disruption of the cytoskeleton, oxidative stress, and protein phosphatase inhibition in the hippocampus.
- MCLR-induced tau hyperphosphorylation, memory deficits, and neuronal apoptosis suggest a potential role in Alzheimer's disease pathogenesis.
